PRISM BioLab Co.,LTD (206A.T)

JPY 292.0

(-1.68%)

Total Liabilities Summary of PRISM BioLab Co.,LTD

  • PRISM BioLab Co.,LTD's latest annual total liabilities in 2023 was 63.41 Million JPY , down -2.79% from previous year.
  • PRISM BioLab Co.,LTD's latest quarterly total liabilities in 2024 Q3 was 1.12 Billion JPY , up 44.94% from previous quarter.
  • PRISM BioLab Co.,LTD reported annual total liabilities of 65.22 Million JPY in 2022, down 0.0% from previous year.
  • PRISM BioLab Co.,LTD reported quarterly total liabilities of 774.67 Million JPY for 2024 Q2, down 0.0% from previous quarter.
  • PRISM BioLab Co.,LTD reported quarterly total liabilities of 63.41 Million JPY for 2023 FY, down -2.79% from previous quarter.

Annual Total Liabilities Chart of PRISM BioLab Co.,LTD (2023 - 2022)

Historical Annual Total Liabilities of PRISM BioLab Co.,LTD (2023 - 2022)

Year Total Liabilities Total Liabilities Growth
2023 63.41 Million JPY -2.79%
2022 65.22 Million JPY 0.0%

Peer Total Liabilities Comparison of PRISM BioLab Co.,LTD

Name Total Liabilities Total Liabilities Difference
KOHJIN BIO CO LTD 3.24 Billion JPY 98.047%
GNI Group Ltd. 26.34 Billion JPY 99.759%
Linical Co., Ltd. 10.3 Billion JPY 99.385%
Trans Genic Inc. 3.81 Billion JPY 98.337%
MEDINET Co., Ltd. 590.2 Million JPY 89.256%
Soiken Holdings Inc. 697.02 Million JPY 90.903%
Cytori Cell Research Institute, Inc. 3.02 Billion JPY 97.901%
AnGes, Inc. 2.78 Billion JPY 97.727%
OncoTherapy Science, Inc. 513.6 Million JPY 87.654%
Nxera Pharma Co., Ltd. 90.38 Billion JPY 99.93%
Immuno-Biological Laboratories Co., Ltd. 353.27 Million JPY 82.05%
NanoCarrier Co., Ltd. 1.64 Billion JPY 96.157%
Carna Biosciences, Inc. 472.35 Million JPY 86.576%
CanBas Co., Ltd. 91.98 Million JPY 31.066%
D. Western Therapeutics Institute, Inc. 1.09 Billion JPY 94.202%
RaQualia Pharma Inc. 809.83 Million JPY 92.17%
Chiome Bioscience Inc. 593.73 Million JPY 89.32%
Kidswell Bio Corporation 4.25 Billion JPY 98.509%
PeptiDream Inc. 29.11 Billion JPY 99.782%
Oncolys BioPharma Inc. 566.5 Million JPY 88.807%
Ribomic Inc. 155.8 Million JPY 59.302%
SanBio Company Limited 2.25 Billion JPY 97.188%
Healios K.K. 11.28 Billion JPY 99.438%
BrightPath Biotherapeutics Co., Ltd. 251.26 Million JPY 74.764%
Kubota Pharmaceutical Holdings Co., Ltd. 369 Million JPY 82.815%
Delta-Fly Pharma, Inc. 241.49 Million JPY 73.743%
StemRIM 187 Million JPY 66.09%
CellSource Co., Ltd. 677.73 Million JPY 90.644%
FunPep Company Limited 189.32 Million JPY 66.507%
Kringle Pharma, Inc. 596.95 Million JPY 89.378%
Stella Pharma Corporation 1.44 Billion JPY 95.607%
TMS Co., Ltd. 97.68 Million JPY 35.089%
Noile-Immune Biotech Inc. 91.49 Million JPY 30.694%
Cuorips Inc. 200.96 Million JPY 68.446%
K Pharma,Inc. 209.13 Million JPY 69.679%
Takara Bio Inc. 11.42 Billion JPY 99.445%
ReproCELL Incorporated 741.03 Million JPY 91.443%
PhoenixBio Co., Ltd. 917.71 Million JPY 93.09%
StemCell Institute Inc. 3.85 Billion JPY 98.353%
Japan Tissue Engineering Co., Ltd. 908.43 Million JPY 93.02%
CellSeed Inc. 301.04 Million JPY 78.937%